Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 25Unknown 14Active not recruiting 5Terminated 4Withdrawn 1Recruiting 1Not yet recruiting 1

Sponsor Class

INDUSTRY 4

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Breast 4

Conditions

Breast Neoplasms 4

Interventions

Trastuzumab 78Capecitabine 59Cyclophosphamide 54Paclitaxel 52Docetaxel 50Letrozole 44Fulvestrant 43Lapatinib 34Doxorubicin 31Carboplatin 31Vinorelbine 30Bevacizumab 29Anastrozole 28pembrolizumab 26exemestane 24Tamoxifen 23Gemcitabine 22Radiotherapy 21Albumin-Bound Paclitaxel 19Taxes 17Everolimus 17Epirubicin 15pertuzumab 13Ado-Trastuzumab Emtansine 13130-nm albumin-bound paclitaxel 13palbociclib 12Magnetic Resonance Spectroscopy 12liposomal doxorubicin 11atezolizumab 11Filgrastim 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × Breast Neoplasms × Mammography × Clear all
NCT03417024 2019-09-09

Automated Breast Ultrasound Case Collection Registry

GE Healthcare

Terminated
13 enrolled 7 charts
Breast

Breast Neoplasms

NCT02324205 2019-02-26

ADAPT

GE Healthcare

Phase NA Terminated
196 enrolled 9 charts
Breast

Breast Neoplasms

NCT02540083 2019-02-05

ADAPT-ENRICH

GE Healthcare

Phase NA Terminated
94 enrolled 9 charts
Breast

Breast Neoplasms

NCT02042456 2015-10-20

Automated Breast Ultrasound and Digital Breast Tomosynthesis Screening Compared to Full Field Digital Mammography in Women With Dense Breasts

GE Healthcare

Terminated
124 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡